After a Vaccine – What? The Shift from Research and Discovery to Communications
Eye on FDA
SEPTEMBER 10, 2020
Vaccines for COVID-19 are the focus of the moment – politically and scientifically speaking. Scientifically, there was the big news that a vaccine trial had experienced a serious adverse event bringing a pause to bear in its continuation, likely throwing further cold water on the political side of the equation.
Let's personalize your content